| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | $44.13K |
| R&D | – | – | – | – | – |
| SG&A | $33.71K | $37.01K | $35.27K | $56.87K | $24.13K |
| Operating Income | -$33.71K | -$37.01K | -$35.27K | -$56.87K | -$90.02K |
| Interest Expense | $6.66K | $5.34K | $3.04K | $11.18K | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$40.37K | -$42.35K | -$38.31K | -$68.04K | -$90.02K |
| EPS (basic) | -0.0100 | -0.0100 | -0.0100 | -0.0100 | -0.0200 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | $5.20M | $5.20M | – | – | – |